HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuliya Sharkovska Selected Research

8- (3- amino- 1- piperidinyl)- 7- (2- butyn- 1- yl)- 1- ((4,6- dimethyl- 2- pyrimidinyl)methyl)- 3- methylxanthine

7/2013The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuliya Sharkovska Research Topics

Disease

6Fibrosis (Cirrhosis)
05/2016 - 08/2008
4Diabetic Nephropathies (Diabetic Nephropathy)
05/2016 - 01/2012
4Albuminuria
05/2016 - 01/2012
3Hypertension (High Blood Pressure)
01/2011 - 08/2010
2Infarction (Infarctions)
03/2014 - 07/2013
2Ischemia
07/2013 - 01/2011
1Premature Birth (Birth, Premature)
10/2021
1Brain Injuries (Brain Injury)
10/2021
1Hyperoxia
10/2021
1Chronic Renal Insufficiency
05/2016
1Type 2 Diabetes Mellitus (MODY)
11/2014
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2013
1Renovascular Hypertension (Goldblatt Syndrome)
04/2011
1Renal Insufficiency (Renal Failure)
01/2011
1Malignant Hypertension
01/2011
1Acute Kidney Injury (Acute Renal Failure)
01/2011
1Chronic Kidney Failure (Chronic Renal Failure)
01/2011
1Pulmonary Hypertension
08/2010
1Heart Failure
08/2010
1Cardiovascular Diseases (Cardiovascular Disease)
08/2010
1Inflammation (Inflammations)
08/2008
1Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2008
1Pneumonia (Pneumonitis)
08/2008

Drug/Important Bio-Agent (IBA)

4LinagliptinIBA
05/2016 - 01/2012
3Telmisartan (Micardis)FDA Link
05/2016 - 01/2012
3riociguatIBA
01/2012 - 08/2010
3NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2011 - 08/2008
2Glucose (Dextrose)FDA LinkGeneric
05/2016 - 11/2014
2Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
05/2016 - 11/2014
2Dipeptidyl-Peptidase IV InhibitorsIBA
11/2014 - 07/2013
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2012 - 01/2012
2Soluble Guanylyl CyclaseIBA
01/2012 - 08/2010
2CreatinineIBA
01/2011 - 08/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2011 - 08/2010
1ParvalbuminsIBA
10/2021
1Oxygen (Dioxygen)IBA
10/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2014
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
03/2014
1Type 2 Angiotensin ReceptorIBA
03/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2014
1compound 21IBA
03/2014
1CollagenIBA
03/2014
18- (3- amino- 1- piperidinyl)- 7- (2- butyn- 1- yl)- 1- ((4,6- dimethyl- 2- pyrimidinyl)methyl)- 3- methylxanthineIBA
07/2013
1XanthineIBA
07/2013
1Angiotensin Receptor AntagonistsIBA
01/2012
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2012
1Losartan (Cozaar)FDA LinkGeneric
04/2011
1Neprilysin (Neutral Endopeptidase)IBA
01/2011
1salicylhydroxamic acid (SHAM)IBA
01/2011
1AlbuminsIBA
01/2011
1Endothelin-Converting EnzymesIBA
01/2011
1Atrial Natriuretic Factor (ANF)IBA
08/2010
1ReninIBA
08/2010
1Urea (Carbamide)FDA LinkGeneric
08/2010
1LU 224332IBA
08/2008
1Endothelins (Endothelin)IBA
08/2008

Therapy/Procedure

1Therapeutics
05/2016
1Surgical Instruments (Clip)
04/2011
1Nephrectomy
08/2010